Crystal structures and Hirshfeld surface analyses of 4-benzyl-6-phenyl-4,5-di-hydro-pyridazin-3(2H)-one and methyl 2-[5-(2,6-di-chloro-benz-yl)-6-oxo-3-phenyl-1,4,5,6-tetra-hydropyridazin-1-yl]acetate.
Journal: 2019/November - Acta Crystallographica Section E: Crystallographic Communications
ISSN: 2056-9890
Abstract:
The asymmetric units of the title compounds both contain one nonplanar mol-ecule. In 4-benzyl-6-phenyl-4,5-di-hydro-pyridazin-3(2H)-one, C17H14N2O, (I), the phenyl and pyridazine rings are twisted with respect to each other, making a dihedral angle of 46.69 (9)°; the phenyl ring of the benzyl group is nearly perpendicular to the plane of the pyridazine ring, the dihedral angle being 78.31 (10)°. In methyl 2-[5-(2,6-di-chloro-benz-yl)-6-oxo-3-phenyl-1,4,5,6-tetra-hydropyridazin-1-yl]acetate, C20H16Cl2N2O3, (II), the phenyl and pyridazine rings are twisted with respect to each other, making a dihedral angle of 21.76 (18)°, whereas the phenyl ring of the di-chloro-benzyl group is inclined to the pyridazine ring by 79.61 (19)°. In the crystal structure of (I), pairs of N-H⋯O hydrogen bonds link the mol-ecules into inversion dimers with an R22(8) ring motif. In the crystal structure of (II), C-H⋯O hydrogen bonds generate dimers with R12(7), R22(16) and R22(18) ring motifs. The Hirshfeld surface analyses of compound (I) suggests that the most significant contributions to the crystal packing are by H⋯H (48.2%), C⋯H/H⋯C (29.9%) and O⋯H/H⋯O (8.9%) contacts. For compound (II), H⋯H (34.4%), C⋯H/H⋯C (21.3%) and O⋯H/H⋯O (16.5%) inter-actions are the most important contributions.
Relations:
Content
Chemicals
(1)
Genes
(1)
Processes
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Acta Crystallogr E Crystallogr Commun 75(Pt 11): 1679-1684

Crystal structures and Hirshfeld surface analyses of 4-benzyl-6-phenyl-4,5-di­hydro­pyridazin-3(2<em>H</em>)-one and methyl 2-[5-(2,6-di­chloro­benz­yl)-6-oxo-3-phenyl-1,4,5,6-tetra­hydropyridazin-1-yl]acetate

Chemical context

Pyridazines are an important family of six-membered aromatic heterocycles (Akhtar et al., 2016). The chemistry of pyridazinones has been an inter­esting field of research for decades and this nitro­gen-containing heterocycle has become a scaffold of choice for the development of potential drug candidates (Dubey &amp; Bhosle, 2015). Pyridazinone is an important pharmacophore possessing a wide range of biological applications (Asif, 2014). A review of the literature revealed that substituted pyridazinones have received a lot of attention in recent years because of their significant potential as anti­microbial (Sönmez et al., 2006), anti­hypertensive (Siddiqui et al., 2011), anti­depressant (Boukharsa et al., 2016), anti-HIV (Livermore et al., 1993) and anti-inflammatory (Barberot et al., 2018) agents.

We report herein the syntheses and crystal and mol­ecular structures of the pyridazinone derivatives 4-benzyl-6-phenyl-4,5-di­hydro­pyridazin-3(2H)-one, (I), and methyl 2-[5-(2,6-di­chloro­benz­yl)-6-oxo-3-phenyl-1,4,5,6-tetra­hydropyridazin-1-yl]acetate, (II), as well as the analyses of their Hirshfeld surfaces.

Structural commentary

The mol­ecular structures of compounds (I) and (II) are illustrated in Figs. 1 and 2, respectively. The common moiety for (I) and (II) is 4-benzyl-6-phenyl-4,5-di­hydro­pyridazin-3(2H)-one. The differences between (I) and (II) pertain to the addition of two chloro groups at the C2 and C6 ring positions of the benzyl group and N-alkyl­ation of pyridazinone at the 2-position with an ethyl acetate group for (II). In (I), the phenyl ring (atoms C12–C17) and the pyridazine ring (N1/N2/C11/C10/C2/C1) are twisted with respect to each other, making a dihedral angle of 46.69 (9)°; the phenyl ring of the benzyl group (C4–C9) is nearly perpendicular to the pyridazine ring, with a dihedral angle of 78.31 (10)° (Fig. 1). In (II), the phenyl ring (C11–C16) and the pyridazine ring (N1/N2/C17/C8/C9/C10) are twisted with respect to each other, making a dihedral angle of 21.76 (18)°; the phenyl ring (C1–C6) of the benzyl group is inclined to the pyridazine ring by 79.61 (19)°. The meth­oxy group in (II) is disordered over two sets of sites with an occupancy ratio of 0.626 (11):0.374 (11) (Fig. 2). In (I), the carbonyl group has a C1=O1 bond length of 1.243 (2) Å, and the C1—N1 and C11—N2 bond lengths in the pyridazine ring are 1.363 (2) and 1.304 (2) Å, respectively. The corresponding values in (II) are 1.229 (5) Å for C17=O1, 1.388 (5) Å for C17—N2 and 1.299 (4) Å for C10—N1. The N1—N2 bond lengths in the structures are virtually the same, with values of 1.348 (2) Å in (I) and 1.353 (4) Å in (II).

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-scheme1.jpg

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig1.jpg

The mol­ecular structure of compound (I), with the atom labelling. Displacement ellipsoids are drawn at the 30% probability level.

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig2.jpg

The mol­ecular structure of compound (II), with the atom labelling. Displacement ellipsoids are drawn at the 30% probability level.

Supra­molecular features

In the crystal of (I), mol­ecules are linked by C—H⋯O hydrogen bonds (Table 1) between the methine C10—H10 group and the carbonyl O1 atom of an adjacent mol­ecule (Fig. 3a), and by a pair of N—H⋯O hydrogen bonds forming inversion dimers with an An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi1.jpg(8) ring motif (Fig. 3b). The dimers are linked by weak π–π inter­actions, with a centroid-to-centroid distance of 3.957 (2) Å for Cg1 and Cg2, where Cg1 is the centroid of the N1/N2/C11/C10/C2/C1 ring and Cg2 that of the C12–C17 phenyl ring. In this way, a three-dimensional network is formed.

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig3.jpg

(a) A portion of the crystal structure of compound (I), viewed along the b-axis direction, emphasizing the C—H⋯O inter­actions, shown as green dashed lines. (b) A view of the crystal packing, showing additional N—H⋯O hydrogen bonds (pink dashed lines) forming inversion dimers with an An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi1.jpg(8) ring motif (Table 1).

Table 1

Hydrogen-bond geometry (Å, °) for (I)
D—H⋯AD—HH⋯ADAD—H⋯A
C10—H10⋯O10.932.483.404 (2)172
N1—H1⋯O10.937 (18)1.855 (19)2.7873 (19)173.0 (16)

Symmetry codes: (i) An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi7.jpg; (ii) An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi8.jpg.

In the crystal of (II), mol­ecules are connected via C—H⋯O hydrogen bonds between aryl groups and the carbonyl O1 atom (Table 2), whereby C9—H9⋯O2 and C12—H12⋯O2 hydrogen bonds generate An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi3.jpg(7) motifs (Fig. 4); likewise, An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi1.jpg(16) and An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi1.jpg(18) ring motifs are also observed.

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig4.jpg

A portion of the crystal structure of compound (II). Dashed light-blue lines denote inter­molecular C—H⋯O hydrogen bonds.

Table 2

Hydrogen-bond geometry (Å, °) for (II)
D—H⋯AD—HH⋯ADAD—H⋯A
C9—H9⋯O20.932.503.337 (4)150
C12—H12⋯O20.932.403.326 (4)174

Symmetry code: (i) An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi9.jpg.

Database survey

A search of the Cambridge Structural Database (CSD, Version 5.40, update of February 2019; Groom et al., 2016) for the 4-benzyl-6-phenyl­pyridazin-3(2H)-one skeleton yielded three hits, namely 4-(2-chloro-6-fluoro­phen­yl)-2,5-dioxo-8-phenyl-1,2,3,4,5,6-hexa­hydro­pyrido[2,3-d]pyridazine (BARQOA; Pita et al., 2000), 4-(2-chloro-5-nitro­phen­yl)-2,5-dioxo-8-phenyl-1,2,3,4,5,6-hexa­hydro­pyrido[2,3-d]pyridazine (BARQUG; Pita et al., 2000) and 4-benzyl-6-p-tolyl­pyridazin-3(2H)-one (YOTVIN; Oubair et al., 2009). In YOTVIN, the mol­ecules are connected two-by-two through N—H⋯O hydrogen bonds, with an An external file that holds a picture, illustration, etc.
Object name is e-75-01679-efi1.jpg(8) graph-set motif, building up a pseudo-dimer arranged around an inversion centre. In the three structures, the C—N bonds in the pyridazine rings correspond to C1—N1 in the structure of (I) [1.363 (2) Å], with a value of 1.363 (2) Å for BARQOA, 1.364 (7) Å for BARQUG and 1.350 (2) Å for YOTVIN. The pyridazinone ring in each mol­ecule is essentially planar, as in the structures of (I) and (II). The conformations of all three compounds resemble those of compounds (I) and (II), with the dihedral angles between the planes of the pyridazine and phenyl rings varying in the range 27.35–82.0°, compared to 46.69 (9) and 21.76 (18)° in (I) and (II), respectively.

Hirshfeld surface analysis

Hirshfield surface analyses (Spackman &amp; Jayatilaka, 2009) were carried out using CrystalExplorer (Version 17.5; Turner et al., 2017). The Hirshfeld surfaces and their associated two-dimensional fingerprint plots were used to qu­antify the various inter­molecular inter­actions in the structures of the title compounds. Calculations of the mol­ecular Hirshfeld surfaces (HS) were performed using a standard (high) surface resolution with the three-dimensional dnorm surfaces mapped over a fixed colour scale of −0.6062 (red) to 1.3165 a.u. (blue) for (I) and of −0.2803 (red) to 1.5329 a.u. (blue) for (II). The red spots on the surface indicate the contacts involved in hydrogen bonding. Fig. 5(a) illustrates the inter­molecular N—H⋯O hydrogen bonding in (I), with dnorm mapped on the Hirshfeld surface. Likewise, C—H⋯O hydrogen bonding is visualized in Fig. 5(b) for compound (II).

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig5.jpg

dnorm mapped on Hirshfeld surfaces for visualizing the inter­molecular inter­actions of (a) compound (I) and (b) compound (II).

Fig. 6 shows the two-dimensional fingerprint plot of the sum of the contacts contributing to the Hirhsfeld surface of compound (I), represented in normal mode. H⋯H contacts clearly make the most significant contribution to the Hirshfeld surface (48.2%). A significant contribution of H⋯H inter­actions to the total HS (72.2%) was also reported by Ilmi et al. (2019) for a similar compound. In addition, C⋯H/H⋯C and O⋯H/H⋯O contacts contribute 29.9 and 8.9%, respectively, to the Hirshfeld surface. In particular, the O⋯H/H⋯O contacts indicate the presence of inter­molecular N—H⋯O and C—H⋯O inter­actions.

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig6.jpg

Two-dimensional fingerprint plots of compound (I) showing the relative contributions of the atom pairs to the Hirshfeld surface.

Similarly, Fig. 7 illustrates the two-dimensional fingerprint plot of the sum of the contacts contributing to the Hirhsfeld surface of compound (II). The H⋯H inter­actions appear in the middle of the scattered points in the two-dimensional fingerprint plots, with a contribution to the overall Hirshfeld surface of 34.4% (Fig. 7b). The contributions (16.5%) from the O⋯H/H⋯O contacts, corresponding to the C—H⋯O inter­actions, are represented by a pair of sharp spikes characteristic of such hydrogen bonding (Fig. 7d).

An external file that holds a picture, illustration, etc.
Object name is e-75-01679-fig7.jpg

Two-dimensional fingerprint plots of compound (II) showing the relative contributions of the atom pairs to the Hirshfeld surface.

Synthesis and crystallization

For the preparation of compound (I), sodium hydroxide (0.5 g, 3.5 mmol) was added to a solution (0.15 g, 1 mmol) of 6-phenyl-4,5-di­hydro­pyridazin-3(2H)-one and benzaldehyde (0.11 g, 1 mmol) in 30 ml of ethanol. The solvent was evaporated under vacuum and the residue was purified by silica-gel column chromatography using hexa­ne/ethyl acetate (7:3 v/v). Colourless single crystals were obtained by slow evaporation at room temperature.

For the preparation of compound (II), potassium carbonate (0.50 g, 3.5 mmol) was added to a solution (0.83 g, 2.5 mmol) of 4-(2,6-di­chloro­benz­yl)-6-phenyl­pyridazin-3(2H)-one in 30 ml of tetra­hydro­furan (THF). The mixture was refluxed for 1 h. After cooling, ethyl bromo­acetate (0.50 g, 3 mmol) was added and the mixture was refluxed for 8 h. The solid material which formed was removed by filtration and the solvent evaporated in vacuo. The residue was purified by silica-gel column chromatography using hexa­ne/ethyl acetate (4:6 v/v). Slow evaporation at room temperature led to colourless single crystals.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 3. For the structure of compound (I), the N-bound H atom was located in a difference Fourier map and refined with N—H = 0.86 Å. For the refinement of structure (II), reflections with a θ angle greater than 28° were omitted from the refinement due to their very weak intensities. The meth­oxy group (O3—C20) in this compound was found to be disordered over two sets of sites and was refined with an occupancy ratio of 0.626 (11):0.374 (11) (SIMU, DELU and ISOR commands in SHELX; Sheldrick, 2015b). For both structures, the C-bound H atoms were positioned geometrically and refined using a riding model, with C—H = 0.93–0.97 Å and Uiso(H) = 1.5Ueq(C) for methyl H atoms or 1.2Ueq(C) otherwise.

Table 3

Experimental details
(I)(II)
Crystal data
Chemical formulaC17H14N2OC20H16Cl2N2O3
Mr262.30403.25
Crystal system, space groupMonoclinic, P21/cMonoclinic, P21/c
Temperature (K)296296
a, b, c (Å)10.819 (3), 11.501 (3), 11.187 (4)11.2730 (13), 12.3808 (9), 14.1405 (15)
β (°)90.93 (3)92.801 (9)
V)1391.7 (7)1971.2 (3)
Z44
Radiation typeMo KαMo Kα
μ (mm)0.080.35
Crystal size (mm)0.78 × 0.71 × 0.590.80 × 0.76 × 0.60
Data collection
DiffractometerStoe IPDS 2Stoe IPDS 2
Absorption correctionIntegration (X-RED32; Stoe &amp; Cie, 2002)Integration (X-RED32; Stoe &amp; Cie, 2002)
Tmin, Tmax0.943, 0.9630.762, 0.832
No. of measured, independent and observed [I > 2σ(I)] reflections14296, 4234, 172819293, 6015, 1892
Rint0.0840.095
(sin θ/λ)max)0.7230.716
Refinement
R[F > 2σ(F)], wR(F), S0.056, 0.104, 0.880.068, 0.231, 0.83
No. of reflections42346015
No. of parameters185265
No. of restraints068
H-atom treatmentH atoms treated by a mixture of independent and constrained refinementH-atom parameters constrained
Δρmax, Δρmin (e Å)0.12, −0.220.96, −0.28

Computer programs: X-AREA (Stoe &amp; Cie, 2002), X-RED (Stoe &amp; Cie, 2002), SHELXT2017 (Sheldrick, 2015a), SHELXL2017 (Sheldrick, 2015b), PLATON (Spek, 2009) and WinGX (Farrugia, 2012).

Laboratory of Applied Chemistry and Environment (LCAE), Faculty of Sciences, Mohamed I University, 60000 Oujda, Morocco,
Department of Physics, Faculty of Arts and Sciences, Ondokuz Mayıs University, 55139 Kurupelit, Samsun, Turkey,
Laboratory of Organic Synthesis, Extraction and Valorization, Faculty of Sciences, Ain Chok, University Hassan II, Casablanca, Rabat, Morocco,
Laboratory of Plant Chemistry, Organic and Bioorganic Synthesis, URAC23, Faculty of Science, B.P. 1014, GEOPAC Research Center, Mohammed V University, Rabat, Morocco,
Correspondence e-mail: moc.liamg@68uodads, moc.liamg@58zisnak.igves
Received 2019 Jul 29; Accepted 2019 Oct 8.
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Abstract

The asymmetric units of the title compounds both contain one nonplanar mol­ecule. In 4-benzyl-6-phenyl-4,5-di­hydro­pyridazin-3(2H)-one, C17H14N2O, (I), the phenyl and pyridazine rings are twisted with respect to each other, making a dihedral angle of 46.69 (9)°; the phenyl ring of the benzyl group is nearly perpendicular to the plane of the pyridazine ring, the dihedral angle being 78.31 (10)°. In methyl 2-[5-(2,6-di­chloro­benz­yl)-6-oxo-3-phenyl-1,4,5,6-tetra­hydropyridazin-1-yl]acetate, C20H16Cl2N2O3, (II), the phenyl and pyridazine rings are twisted with respect to each other, making a dihedral angle of 21.76 (18)°, whereas the phenyl ring of the di­chloro­benzyl group is inclined to the pyridazine ring by 79.61 (19)°. In the crystal structure of (I), pairs of N—H⋯O hydrogen bonds link the mol­ecules into inversion dimers with an R2(8) ring motif. In the crystal structure of (II), C—H⋯O hydrogen bonds generate dimers with R1(7), R2(16) and R2(18) ring motifs. The Hirshfeld surface analyses of compound (I) suggests that the most significant contributions to the crystal packing are by H⋯H (48.2%), C⋯H/H⋯C (29.9%) and O⋯H/H⋯O (8.9%) contacts. For compound (II), H⋯H (34.4%), C⋯H/H⋯C (21.3%) and O⋯H/H⋯O (16.5%) inter­actions are the most important contributions.

Keywords: crystal structure, pyridazine, hydrogen bonding, Hirshfeld surface analysis
Abstract

Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989019013707/wm5515sup1.cif

Click here to view.(502K, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989019013707/wm5515Isup4.hkl

Click here to view.(337K, hkl)

Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989019013707/wm5515IIsup5.hkl

Click here to view.(379K, hkl)
Click here for additional data file.(5.4K, cml)

Supporting information file. DOI: 10.1107/S2056989019013707/wm5515Isup4.cml

Click here for additional data file.(5.4K, cml)
Click here for additional data file.(6.8K, cml)

Supporting information file. DOI: 10.1107/S2056989019013707/wm5515IIsup5.cml

Click here for additional data file.(6.8K, cml)

CCDC references: 1958029, 1958030, 1958029, 1958030

Additional supporting information: crystallographic information; 3D view; checkCIF report

supplementary crystallographic information

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Crystal data

C17H14N2OF(000) = 552
Mr = 262.30Dx = 1.252 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 10.819 (3) ÅCell parameters from 15196 reflections
b = 11.501 (3) Åθ = 3.2–31.3°
c = 11.187 (4) ŵ = 0.08 mm1
β = 90.93 (3)°T = 296 K
V = 1391.7 (7) Å3Prism, colourless
Z = 40.78 × 0.71 × 0.59 mm

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Data collection

STOE IPDS 2 diffractometer4234 independent reflections
Radiation source: sealed X-ray tube, 12 x 0.4 mm long-fine focus1728 reflections with I > 2σ(I)
Detector resolution: 6.67 pixels mm-1Rint = 0.084
rotation method scansθmax = 30.9°, θmin = 3.2°
Absorption correction: integration (X-RED32; Stoe &amp; Cie, 2002)h = −13→15
Tmin = 0.943, Tmax = 0.963k = −16→16
14296 measured reflectionsl = −15→16

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Refinement

Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: mixed
R[F > 2σ(F)] = 0.056H atoms treated by a mixture of independent and constrained refinement
wR(F) = 0.104w = 1/[σ(Fo) + (0.034P)] where P = (Fo + 2Fc)/3
S = 0.88(Δ/σ)max < 0.001
4234 reflectionsΔρmax = 0.12 e Å3
185 parametersΔρmin = −0.22 e Å3

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å)

xyzUiso*/Ueq
O10.62706 (11)0.40510 (10)0.98172 (10)0.0511 (3)
N10.48091 (14)0.45541 (13)0.84500 (12)0.0441 (4)
N20.41272 (13)0.44540 (12)0.74360 (12)0.0441 (4)
C110.44527 (16)0.36178 (14)0.67190 (15)0.0405 (4)
C20.61718 (15)0.30051 (13)0.79846 (14)0.0392 (4)
C10.57821 (16)0.38841 (14)0.88184 (15)0.0406 (4)
C100.54855 (16)0.28797 (14)0.69831 (14)0.0446 (4)
H100.5687120.2295950.6445120.053*
C30.73380 (16)0.23298 (14)0.82536 (15)0.0475 (4)
H3A0.7283340.1568340.7883630.057*
H3B0.7429720.2222040.9110460.057*
C120.37007 (16)0.34746 (15)0.56177 (15)0.0440 (4)
C40.84563 (17)0.29722 (15)0.77837 (16)0.0475 (4)
C130.33000 (17)0.23823 (18)0.52768 (17)0.0556 (5)
H130.3527470.1737420.5731150.067*
C50.9009 (2)0.38546 (17)0.84222 (19)0.0628 (5)
H50.8729350.4033990.9181910.075*
C170.33608 (18)0.44182 (17)0.49299 (16)0.0559 (5)
H170.3621990.5159990.5147750.067*
C150.22392 (19)0.3182 (2)0.35938 (19)0.0733 (6)
H150.1747050.3086620.2911530.088*
C140.25661 (19)0.2239 (2)0.4269 (2)0.0684 (6)
H140.2293890.1501090.4049940.082*
C90.8903 (2)0.2735 (2)0.66590 (19)0.0735 (6)
H90.8543880.2140960.6208050.088*
C160.2635 (2)0.4265 (2)0.39206 (18)0.0722 (6)
H160.2412510.4905230.3456960.087*
C60.9983 (2)0.4484 (2)0.7947 (3)0.0943 (9)
H61.0346280.5078830.8392570.113*
C71.0412 (3)0.4237 (3)0.6833 (4)0.1156 (12)
H71.1062220.4659520.6517150.139*
C80.9869 (3)0.3360 (3)0.6192 (3)0.1073 (10)
H81.0154100.3182690.5433880.129*
H10.4486 (16)0.5073 (16)0.9010 (16)0.060 (6)*

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Atomic displacement parameters (Å)

U11U22U33U12U13U23
O10.0612 (8)0.0586 (8)0.0334 (6)0.0067 (6)−0.0021 (6)−0.0081 (6)
N10.0550 (10)0.0423 (9)0.0351 (8)0.0067 (7)0.0024 (7)−0.0069 (7)
N20.0504 (9)0.0452 (9)0.0366 (8)0.0039 (7)0.0012 (7)−0.0033 (7)
C110.0447 (10)0.0403 (10)0.0367 (9)−0.0009 (8)0.0043 (8)−0.0012 (7)
C20.0466 (10)0.0351 (9)0.0360 (9)−0.0009 (8)0.0024 (8)0.0002 (7)
C10.0489 (11)0.0405 (10)0.0327 (10)−0.0038 (9)0.0053 (9)0.0002 (7)
C100.0539 (11)0.0399 (10)0.0399 (10)0.0019 (9)0.0004 (9)−0.0092 (8)
C30.0597 (12)0.0403 (9)0.0423 (9)0.0075 (9)−0.0055 (9)−0.0020 (8)
C120.0397 (10)0.0539 (11)0.0384 (10)0.0057 (9)0.0028 (8)−0.0086 (8)
C40.0434 (10)0.0516 (10)0.0474 (10)0.0131 (9)−0.0041 (9)0.0031 (9)
C130.0514 (11)0.0595 (12)0.0556 (11)0.0084 (10)−0.0070 (10)−0.0142 (10)
C50.0614 (13)0.0666 (13)0.0601 (13)−0.0035 (11)−0.0142 (11)0.0065 (10)
C170.0572 (13)0.0602 (12)0.0501 (11)0.0030 (10)−0.0025 (10)0.0021 (10)
C150.0566 (14)0.113 (2)0.0494 (12)0.0119 (14)−0.0123 (10)−0.0194 (14)
C140.0531 (13)0.0787 (15)0.0731 (14)0.0052 (11)−0.0094 (11)−0.0305 (13)
C90.0715 (15)0.0874 (16)0.0619 (13)0.0268 (13)0.0118 (12)−0.0014 (12)
C160.0694 (15)0.0965 (18)0.0504 (12)0.0146 (13)−0.0086 (12)0.0098 (12)
C60.0636 (16)0.097 (2)0.121 (2)−0.0194 (15)−0.0214 (17)0.0302 (18)
C70.0527 (17)0.144 (3)0.151 (3)0.0057 (18)0.0204 (19)0.063 (3)
C80.077 (2)0.149 (3)0.096 (2)0.036 (2)0.0412 (17)0.022 (2)

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Geometric parameters (Å, º)

O1—C11.243 (2)C13—C141.378 (3)
N1—N21.348 (2)C13—H130.9300
N1—C11.363 (2)C5—C61.390 (3)
N1—H10.937 (18)C5—H50.9300
N2—C111.3044 (19)C17—C161.376 (3)
C11—C101.430 (2)C17—H170.9300
C11—C121.475 (2)C15—C141.365 (3)
C2—C101.342 (2)C15—C161.365 (3)
C2—C11.443 (2)C15—H150.9300
C2—C31.508 (2)C14—H140.9300
C10—H100.9300C9—C81.379 (4)
C3—C41.519 (2)C9—H90.9300
C3—H3A0.9700C16—H160.9300
C3—H3B0.9700C6—C71.367 (4)
C12—C171.377 (2)C6—H60.9300
C12—C131.381 (2)C7—C81.364 (4)
C4—C51.373 (3)C7—H70.9300
C4—C91.382 (3)C8—H80.9300
N2—N1—C1128.00 (14)C14—C13—H13119.7
N2—N1—H1114.4 (11)C12—C13—H13119.7
C1—N1—H1116.9 (11)C4—C5—C6120.8 (2)
C11—N2—N1115.52 (15)C4—C5—H5119.6
N2—C11—C10121.89 (16)C6—C5—H5119.6
N2—C11—C12116.44 (15)C16—C17—C12120.1 (2)
C10—C11—C12121.67 (15)C16—C17—H17120.0
C10—C2—C1116.83 (16)C12—C17—H17120.0
C10—C2—C3124.15 (15)C14—C15—C16120.0 (2)
C1—C2—C3118.96 (15)C14—C15—H15120.0
O1—C1—N1119.96 (15)C16—C15—H15120.0
O1—C1—C2124.38 (17)C15—C14—C13119.9 (2)
N1—C1—C2115.66 (15)C15—C14—H14120.1
C2—C10—C11121.92 (15)C13—C14—H14120.1
C2—C10—H10119.0C8—C9—C4121.3 (2)
C11—C10—H10119.0C8—C9—H9119.3
C2—C3—C4110.44 (14)C4—C9—H9119.3
C2—C3—H3A109.6C15—C16—C17120.6 (2)
C4—C3—H3A109.6C15—C16—H16119.7
C2—C3—H3B109.6C17—C16—H16119.7
C4—C3—H3B109.6C7—C6—C5120.7 (3)
H3A—C3—H3B108.1C7—C6—H6119.6
C17—C12—C13118.88 (17)C5—C6—H6119.6
C17—C12—C11121.17 (16)C8—C7—C6118.9 (3)
C13—C12—C11119.93 (17)C8—C7—H7120.5
C5—C4—C9117.6 (2)C6—C7—H7120.5
C5—C4—C3121.50 (17)C7—C8—C9120.6 (3)
C9—C4—C3120.73 (19)C7—C8—H8119.7
C14—C13—C12120.6 (2)C9—C8—H8119.7
C1—N1—N2—C11−0.7 (2)C2—C3—C4—C582.6 (2)
N1—N2—C11—C10−1.6 (2)C2—C3—C4—C9−93.2 (2)
N1—N2—C11—C12178.58 (15)C17—C12—C13—C14−0.4 (3)
N2—N1—C1—O1−175.85 (16)C11—C12—C13—C14178.07 (17)
N2—N1—C1—C24.0 (2)C9—C4—C5—C60.1 (3)
C10—C2—C1—O1174.96 (17)C3—C4—C5—C6−175.88 (18)
C3—C2—C1—O1−7.8 (2)C13—C12—C17—C16−0.1 (3)
C10—C2—C1—N1−4.9 (2)C11—C12—C17—C16−178.52 (17)
C3—C2—C1—N1172.33 (14)C16—C15—C14—C13−0.3 (3)
C1—C2—C10—C113.1 (2)C12—C13—C14—C150.6 (3)
C3—C2—C10—C11−173.96 (15)C5—C4—C9—C80.0 (3)
N2—C11—C10—C20.3 (3)C3—C4—C9—C8176.0 (2)
C12—C11—C10—C2−179.90 (16)C14—C15—C16—C17−0.2 (3)
C10—C2—C3—C490.0 (2)C12—C17—C16—C150.4 (3)
C1—C2—C3—C4−86.97 (18)C4—C5—C6—C70.0 (4)
N2—C11—C12—C1745.2 (2)C5—C6—C7—C8−0.1 (4)
C10—C11—C12—C17−134.69 (17)C6—C7—C8—C90.1 (4)
N2—C11—C12—C13−133.26 (17)C4—C9—C8—C7−0.1 (4)
C10—C11—C12—C1346.9 (2)

4-Benzyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one (I)  Hydrogen-bond geometry (Å, º)

D—H···AD—HH···AD···AD—H···A
C10—H10···O1i0.932.483.404 (2)172
N1—H1···O1ii0.937 (18)1.855 (19)2.7873 (19)173.0 (16)

Symmetry codes: (i) x, −y+1/2, z−1/2; (ii) −x+1, −y+1, −z+2.

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Crystal data

C20H16Cl2N2O3F(000) = 832
Mr = 403.25Dx = 1.359 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 11.2730 (13) ÅCell parameters from 14081 reflections
b = 12.3808 (9) Åθ = 1.6–30.5°
c = 14.1405 (15) ŵ = 0.35 mm1
β = 92.801 (9)°T = 296 K
V = 1971.2 (3) Å3Cubic, colourless
Z = 40.80 × 0.76 × 0.60 mm

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Data collection

STOE IPDS 2 diffractometer6015 independent reflections
Radiation source: sealed X-ray tube, 12 x 0.4 mm long-fine focus1892 reflections with I > 2σ(I)
Detector resolution: 6.67 pixels mm-1Rint = 0.095
rotation method scansθmax = 30.6°, θmin = 1.8°
Absorption correction: integration (X-RED32; Stoe &amp; Cie, 2002)h = −14→16
Tmin = 0.762, Tmax = 0.832k = −17→17
19293 measured reflectionsl = −20→20

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Refinement

Refinement on F268 restraints
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F > 2σ(F)] = 0.068H-atom parameters constrained
wR(F) = 0.231w = 1/[σ(Fo) + (0.1133P)] where P = (Fo + 2Fc)/3
S = 0.83(Δ/σ)max < 0.001
6015 reflectionsΔρmax = 0.96 e Å3
265 parametersΔρmin = −0.28 e Å3

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å)

xyzUiso*/UeqOcc. (<1)
Cl20.28302 (11)0.78380 (8)0.39545 (9)0.0874 (4)
Cl10.11530 (12)0.56182 (11)0.68990 (9)0.0990 (4)
O10.4761 (2)0.6024 (2)0.73816 (19)0.0734 (8)
O20.7312 (3)0.4765 (2)0.6889 (2)0.0785 (8)
N20.4886 (3)0.4295 (2)0.6878 (2)0.0598 (8)
N10.4620 (3)0.3458 (2)0.6290 (2)0.0589 (8)
C100.3921 (3)0.3643 (2)0.5550 (2)0.0521 (8)
C90.3431 (3)0.4694 (2)0.5375 (3)0.0525 (8)
H90.2939910.4807180.4836170.063*
C80.3664 (3)0.5517 (2)0.5968 (2)0.0522 (8)
C60.1935 (3)0.6695 (3)0.5385 (3)0.0575 (9)
C170.4456 (3)0.5342 (3)0.6787 (3)0.0570 (9)
C110.3627 (3)0.2690 (3)0.4945 (3)0.0555 (9)
C50.1694 (3)0.7216 (3)0.4534 (3)0.0645 (10)
C70.3150 (3)0.6633 (3)0.5872 (3)0.0624 (10)
H7A0.3688060.7075340.5522540.075*
H7B0.3110270.6943490.6499530.075*
C190.6926 (4)0.4357 (3)0.7570 (3)0.0660 (9)
C120.3198 (3)0.2793 (3)0.4022 (3)0.0636 (10)
H120.3119700.3478920.3757770.076*
C180.5661 (3)0.4012 (3)0.7686 (3)0.0659 (10)
H18A0.5638810.3236460.7778730.079*
H18B0.5370300.4351490.8248350.079*
C10.0960 (4)0.6252 (3)0.5811 (3)0.0689 (10)
C160.3768 (4)0.1655 (3)0.5324 (3)0.0702 (11)
H160.4064430.1563630.5944230.084*
C130.2881 (4)0.1900 (3)0.3477 (3)0.0761 (12)
H130.2581830.1990130.2857670.091*
C140.3009 (4)0.0890 (3)0.3850 (3)0.0779 (12)
H140.2791120.0288040.3488340.093*
C150.3463 (4)0.0763 (3)0.4771 (3)0.0832 (13)
H150.3565130.0072580.5020850.100*
C40.0557 (4)0.7290 (4)0.4124 (4)0.0859 (13)
H40.0426960.7651850.3552040.103*
C2−0.0182 (4)0.6326 (4)0.5418 (4)0.0892 (14)
H2−0.0816670.6036910.5729540.107*
C3−0.0371 (4)0.6835 (4)0.4557 (4)0.0965 (16)
H3−0.1131400.6866650.4272090.116*
O3A0.7602 (3)0.3969 (6)0.8303 (3)0.0728 (15)0.626 (11)
C20A0.8977 (5)0.4168 (8)0.8327 (6)0.092 (2)0.626 (11)
H20A0.9188460.4493460.7742250.138*0.626 (11)
H20B0.9385590.3492100.8410050.138*0.626 (11)
H20C0.9199350.4641470.8843680.138*0.626 (11)
O3B0.7492 (6)0.4387 (10)0.8431 (4)0.0755 (19)0.374 (11)
C20B0.8759 (9)0.4925 (14)0.8535 (8)0.091 (3)0.374 (11)
H20D0.9167040.4820910.7962410.137*0.374 (11)
H20E0.9206060.4598310.9054870.137*0.374 (11)
H20F0.8674050.5684350.8652760.137*0.374 (11)

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Atomic displacement parameters (Å)

U11U22U33U12U13U23
Cl20.1012 (9)0.0618 (6)0.0996 (9)0.0013 (6)0.0092 (7)0.0122 (6)
Cl10.1100 (10)0.1085 (9)0.0791 (8)−0.0063 (7)0.0106 (7)0.0075 (7)
O10.0876 (19)0.0628 (15)0.0671 (17)−0.0012 (13)−0.0224 (14)−0.0133 (13)
O20.0850 (19)0.0732 (17)0.0761 (17)−0.0032 (14)−0.0089 (15)0.0184 (15)
N20.0670 (19)0.0536 (17)0.0570 (17)0.0014 (14)−0.0160 (15)0.0007 (15)
N10.0655 (19)0.0484 (16)0.0619 (18)0.0012 (14)−0.0076 (15)0.0044 (15)
C100.0540 (19)0.0444 (17)0.057 (2)−0.0001 (14)−0.0094 (16)0.0043 (16)
C90.0537 (19)0.0460 (17)0.056 (2)0.0014 (14)−0.0114 (16)0.0009 (15)
C80.0517 (19)0.0446 (17)0.059 (2)−0.0005 (14)−0.0086 (15)−0.0009 (15)
C60.061 (2)0.0389 (17)0.071 (2)0.0010 (15)−0.0111 (18)−0.0091 (17)
C170.060 (2)0.0491 (19)0.061 (2)0.0023 (16)−0.0075 (17)−0.0020 (17)
C110.060 (2)0.0422 (18)0.064 (2)0.0032 (15)−0.0006 (17)−0.0027 (16)
C50.070 (2)0.0454 (18)0.078 (3)0.0046 (17)0.000 (2)−0.0051 (18)
C70.063 (2)0.0433 (18)0.079 (3)0.0013 (16)−0.0172 (19)−0.0063 (18)
C190.079 (2)0.0544 (19)0.062 (2)−0.0015 (17)−0.0175 (17)0.0069 (17)
C120.079 (2)0.0496 (19)0.062 (2)0.0016 (18)−0.0031 (19)−0.0021 (17)
C180.067 (2)0.068 (2)0.061 (2)0.0009 (19)−0.0169 (19)0.0138 (19)
C10.068 (3)0.059 (2)0.079 (3)0.0023 (18)−0.005 (2)−0.0094 (19)
C160.093 (3)0.048 (2)0.068 (2)0.0014 (19)−0.012 (2)0.0026 (19)
C130.097 (3)0.066 (3)0.064 (2)0.004 (2)−0.005 (2)−0.013 (2)
C140.097 (3)0.054 (2)0.082 (3)−0.003 (2)−0.001 (2)−0.017 (2)
C150.115 (4)0.044 (2)0.090 (3)−0.003 (2)−0.001 (3)−0.004 (2)
C40.087 (3)0.079 (3)0.089 (3)0.017 (2)−0.022 (3)0.004 (2)
C20.063 (3)0.093 (3)0.111 (4)0.000 (2)0.000 (3)−0.010 (3)
C30.060 (3)0.105 (4)0.122 (4)0.011 (3)−0.025 (3)−0.009 (3)
O3A0.075 (2)0.068 (3)0.072 (2)−0.011 (2)−0.025 (2)0.011 (2)
C20A0.087 (3)0.083 (5)0.105 (5)−0.025 (4)−0.008 (4)0.018 (4)
O3B0.080 (3)0.074 (4)0.070 (3)−0.009 (3)−0.023 (3)0.005 (3)
C20B0.072 (5)0.102 (6)0.100 (6)0.003 (5)0.001 (4)0.024 (6)

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Geometric parameters (Å, º)

Cl2—C51.734 (4)C12—C131.384 (5)
Cl1—C11.731 (4)C12—H120.9300
O1—C171.228 (4)C18—H18A0.9700
O2—C191.189 (5)C18—H18B0.9700
N2—N11.353 (4)C1—C21.380 (6)
N2—C171.388 (4)C16—C151.387 (5)
N2—C181.447 (4)C16—H160.9300
N1—C101.299 (4)C13—C141.363 (6)
C10—C91.430 (4)C13—H130.9300
C10—C111.484 (4)C14—C151.384 (6)
C9—C81.338 (4)C14—H140.9300
C9—H90.9300C15—H150.9300
C8—C171.444 (5)C4—C31.359 (7)
C8—C71.503 (4)C4—H40.9300
C6—C51.381 (5)C2—C31.378 (7)
C6—C11.392 (6)C2—H20.9300
C6—C71.504 (5)C3—H30.9300
C11—C121.376 (5)O3A—C20A1.569 (6)
C11—C161.395 (5)C20A—H20A0.9600
C5—C41.384 (6)C20A—H20B0.9600
C7—H7A0.9700C20A—H20C0.9600
C7—H7B0.9700O3B—C20B1.576 (7)
C19—O3A1.344 (5)C20B—H20D0.9600
C19—O3B1.347 (5)C20B—H20E0.9600
C19—C181.505 (6)C20B—H20F0.9600
N1—N2—C17126.3 (3)N2—C18—H18B109.1
N1—N2—C18114.1 (3)C19—C18—H18B109.1
C17—N2—C18119.6 (3)H18A—C18—H18B107.8
C10—N1—N2117.9 (3)C2—C1—C6122.7 (4)
N1—C10—C9120.9 (3)C2—C1—Cl1117.6 (4)
N1—C10—C11115.7 (3)C6—C1—Cl1119.7 (3)
C9—C10—C11123.3 (3)C15—C16—C11119.6 (4)
C8—C9—C10121.5 (3)C15—C16—H16120.2
C8—C9—H9119.3C11—C16—H16120.2
C10—C9—H9119.3C14—C13—C12119.9 (4)
C9—C8—C17118.9 (3)C14—C13—H13120.1
C9—C8—C7125.6 (3)C12—C13—H13120.1
C17—C8—C7115.5 (3)C13—C14—C15119.7 (4)
C5—C6—C1115.8 (3)C13—C14—H14120.2
C5—C6—C7123.9 (4)C15—C14—H14120.2
C1—C6—C7120.2 (3)C14—C15—C16120.7 (4)
O1—C17—N2119.6 (3)C14—C15—H15119.7
O1—C17—C8126.0 (3)C16—C15—H15119.7
N2—C17—C8114.4 (3)C3—C4—C5120.1 (4)
C12—C11—C16118.5 (3)C3—C4—H4120.0
C12—C11—C10122.1 (3)C5—C4—H4120.0
C16—C11—C10119.4 (3)C3—C2—C1119.2 (5)
C6—C5—C4122.3 (4)C3—C2—H2120.4
C6—C5—Cl2120.1 (3)C1—C2—H2120.4
C4—C5—Cl2117.6 (4)C4—C3—C2119.9 (4)
C8—C7—C6115.2 (3)C4—C3—H3120.1
C8—C7—H7A108.5C2—C3—H3120.1
C6—C7—H7A108.5C19—O3A—C20A118.9 (4)
C8—C7—H7B108.5O3A—C20A—H20A109.5
C6—C7—H7B108.5O3A—C20A—H20B109.5
H7A—C7—H7B107.5H20A—C20A—H20B109.5
O2—C19—O3A124.0 (4)O3A—C20A—H20C109.5
O2—C19—O3B123.0 (4)H20A—C20A—H20C109.5
O2—C19—C18126.5 (3)H20B—C20A—H20C109.5
O3A—C19—C18108.6 (4)C19—O3B—C20B118.9 (5)
O3B—C19—C18108.6 (4)O3B—C20B—H20D109.5
C11—C12—C13121.6 (3)O3B—C20B—H20E109.5
C11—C12—H12119.2H20D—C20B—H20E109.5
C13—C12—H12119.2O3B—C20B—H20F109.5
N2—C18—C19112.6 (3)H20D—C20B—H20F109.5
N2—C18—H18A109.1H20E—C20B—H20F109.5
C19—C18—H18A109.1
C17—N2—N1—C101.9 (5)C16—C11—C12—C131.6 (6)
C18—N2—N1—C10179.5 (3)C10—C11—C12—C13−177.3 (4)
N2—N1—C10—C9−1.2 (5)N1—N2—C18—C19102.0 (4)
N2—N1—C10—C11−178.0 (3)C17—N2—C18—C19−80.2 (4)
N1—C10—C9—C8−0.7 (6)O2—C19—C18—N2−4.0 (6)
C11—C10—C9—C8176.0 (3)O3A—C19—C18—N2−173.8 (4)
C10—C9—C8—C171.8 (5)O3B—C19—C18—N2160.7 (6)
C10—C9—C8—C7−176.9 (4)C5—C6—C1—C2−0.2 (6)
N1—N2—C17—O1179.1 (3)C7—C6—C1—C2177.1 (4)
C18—N2—C17—O11.7 (5)C5—C6—C1—Cl1−177.9 (3)
N1—N2—C17—C8−0.8 (5)C7—C6—C1—Cl1−0.6 (5)
C18—N2—C17—C8−178.2 (3)C12—C11—C16—C15−0.7 (6)
C9—C8—C17—O1179.0 (4)C10—C11—C16—C15178.2 (4)
C7—C8—C17—O1−2.1 (6)C11—C12—C13—C14−1.0 (7)
C9—C8—C17—N2−1.1 (5)C12—C13—C14—C15−0.5 (7)
C7—C8—C17—N2177.8 (3)C13—C14—C15—C161.3 (7)
N1—C10—C11—C12−160.9 (3)C11—C16—C15—C14−0.7 (7)
C9—C10—C11—C1222.3 (6)C6—C5—C4—C3−0.4 (7)
N1—C10—C11—C1620.2 (5)Cl2—C5—C4—C3−178.8 (4)
C9—C10—C11—C16−156.6 (4)C6—C1—C2—C31.7 (7)
C1—C6—C5—C4−0.4 (5)Cl1—C1—C2—C3179.4 (4)
C7—C6—C5—C4−177.6 (4)C5—C4—C3—C21.9 (7)
C1—C6—C5—Cl2178.0 (3)C1—C2—C3—C4−2.5 (7)
C7—C6—C5—Cl20.8 (5)O2—C19—O3A—C20A6.9 (8)
C9—C8—C7—C629.2 (6)C18—C19—O3A—C20A177.1 (5)
C17—C8—C7—C6−149.6 (3)O2—C19—O3B—C20B−3.6 (13)
C5—C6—C7—C8−116.0 (4)C18—C19—O3B—C20B−168.9 (8)
C1—C6—C7—C866.9 (5)

Methyl 2-[5-(2,6-dichlorobenzyl)-6-oxo-3-phenyl-1,4,5,6-tetrahydro-pyridazin-1-yl]acetate (II)  Hydrogen-bond geometry (Å, º)

D—H···AD—HH···AD···AD—H···A
C9—H9···O2i0.932.503.337 (4)150
C12—H12···O2i0.932.403.326 (4)174

Symmetry code: (i) −x+1, −y+1, −z+1.

supplementary crystallographic information

Funding Statement

This work was funded by Ondokuz Mayis Üniversitesi grant PYO·FEN.1906.19.001.

Funding Statement
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.